PULSED AF Post-Approval Study, an Addendum to the PulseSelect™ PFA Global Registry

Status: Recruiting
Location: See all (14) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• A diagnosis of recurrent symptomatic paroxysmal AF or persistent AF

• Refractory to at least one Class I or III antiarrhythmic drug (i.e., not effective, not tolerated, or not desired)

• Patient is ≥ 18 years of age

• Planned pulmonary vein isolation procedure with the commercially available PulseSelect™ PFA System

• Willing and able to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements

Locations
United States
Kentucky
Pikeville Medical Center
RECRUITING
Whitesburg
Massachusetts
Southcoast Health System
RECRUITING
Fall River
Michigan
Beaumont Health System
RECRUITING
Royal Oak
Nebraska
Nebraska Medical Center
RECRUITING
Omaha
New York
Northwell Health Lenox Hill Hospital
RECRUITING
New York
The Valley Hospital
RECRUITING
New York
Ohio
Bethesda North Hospital
RECRUITING
Cincinnati
The Ohio State University Wexner Medical Center
RECRUITING
Columbus
Mount Carmel Grove City Medical Center
RECRUITING
Grove City
Pennsylvania
Doylestown Health Cardiology a division of Doylestown Health Physicians
RECRUITING
Doylestown
South Carolina
AnMed Health Center
RECRUITING
Anderson
Medical University of South Carolina (MUSC)
RECRUITING
Charleston
Texas
Texas Health Research & Education Institute
RECRUITING
Dallas
Virginia
University of Virginia Medical Center
RECRUITING
Charlottesville
Contact Information
Primary
Josman Suri
josman.suri@medtronic.com
7635050262
Time Frame
Start Date: 2024-11-04
Estimated Completion Date: 2029-06-01
Participants
Target number of participants: 580
Treatments
Paroxysmal
Ablation using the PulseSelect™ PFA system
Persistent
Ablation using the PulseSelect™ PFA system
Related Therapeutic Areas
Sponsors
Leads: Medtronic Cardiac Ablation Solutions

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.